Category Archive: Investment Research Blog

2013-11-22T010202Z_1_CBRE9AK1QH900_RTROPTP_3_MARKETS-STOCKS_original

November 22, 2013

Dow ends above 16,000 for first time, boosted by data

By Luke Swiderski – Reuters NEW YORK (Reuters) – The Dow industrials closed above 16,000 for the first time on Thursday as stocks rebounded from three days of weakness, after economic data pointed to a slowly improving labor market and subdued inflation. Financial shares led the market to its first day of gains after three […]

Read More

Biotech

July 23, 2013

Plenty Of Room For Everyone In The Race To FDA Approval For New Hepatitis C Therapies

The United States Preventive Services Task Force, or USPSTF, reversed its stance late on June 25 to conclude that all baby boomers – those people born between 1945 and 1965 – should be tested for hepatitis C. The USPSTF is an influential medical guidelines organization that advises Congress and, as its website reads, “makes recommendations about the […]

Read More

images

June 29, 2013

Why Tesla’s Battery Swapping Won’t Work

Let’s start by stating right up front that this is not a Tesla (TSLA) bashing article. They are clearly a pioneer and a successful one at that. They have built a great car, but more importantly they are doing everything they can to remove the barriers that are currently blocking the EV (Electric Vehicle) revolution. […]

Read More

Screen Shot 2013-04-04 at 11.22.27 AM

May 22, 2013

CrowdGather Restructures To Unlock Value

CrowdGather Inc. (CRWG.OB), operator of a growing portfolio of special interest forums and enthusiast message board communities, recently raised $1 million in a preferred stock financing and began efforts to restructure its business. With these efforts in place, investors may want to take another look at this undervalued Internet stock. Bolstering the Balance Sheet CrowdGather […]

Read More

Sartorius AG

April 20, 2013

This Week in Biotech: Part 1

By Sean Williams | More Articles April 20, 2013 | Comments (0) With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let’s have a look at some of the rulings, studies, and companies that made waves in the sector last week. You can […]

Read More